Table of Contents Author Guidelines Submit a Manuscript
International Journal of Pediatrics
Volume 2011 (2011), Article ID 524520, 6 pages
http://dx.doi.org/10.1155/2011/524520
Clinical Study

Efficacy, Tolerability, and Acceptability of Iron Hydroxide Polymaltose Complex versus Ferrous Sulfate: A Randomized Trial in Pediatric Patients with Iron Deficiency Anemia

Department of Pediatric Hematology/Oncology, Istanbul Medical School, University of Istanbul, Capa 34093, Istanbul, Turkey

Received 23 August 2011; Accepted 29 September 2011

Academic Editor: Frans J. Walther

Copyright © 2011 Beril Yasa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, World Health Report 2002: Reducing Risks, Promoting Healthy Life, World Health Organization, Geneva, Switzerland, 2002.
  2. B. Benoist, E. McLean, I. Egli, and M. Cogswell, Worldwide Prevalence of Anaemia 1993–2005. WHO Global Database of Anaemia, World Health Organization, Geneva, Switzerland, 2008.
  3. S. Hercberg, P. Preziosi, and P. Galan, “Iron deficiency in Europe,” Public Health Nutrition, vol. 4, no. 2B, pp. 537–545, 2001. View at Google Scholar · View at Scopus
  4. World Health Organization, “Guidelines for the Use of Iron Supplements to Prevent and Treat Iron Deficiency Anemia,” 2001, http://www.who.int/nutrition/publications/micronutrients/guidelines_for_Iron_supplementation.pdf. View at Google Scholar
  5. B. Lozoff, J. Beard, J. Connor, B. Felt, M. Georgieff, and T. Schallert, “Long-lasting neural and behavioral effects of iron deficiency in infancy,” Nutrition Reviews, vol. 64, no. 5, pp. S34–S43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. A. C. Looker, P. R. Dallman, M. D. Carroll, E. W. Gunter, and C. L. Johnson, “Prevalence of iron deficiency in the United States,” Journal of the American Medical Association, vol. 277, no. 12, pp. 973–976, 1997. View at Google Scholar · View at Scopus
  7. J. D. Cook, B. S. Skikne, and R. D. Baynes, “Iron deficiency: the global perspective,” Advances in Experimental Medicine and Biology, vol. 356, pp. 219–228, 1994. View at Google Scholar · View at Scopus
  8. P. Jacobs, D. Fransman, and P. Coghlan, “Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron-deficient blood donors,” Journal of Clinical Apheresis, vol. 8, no. 2, pp. 89–95, 1993. View at Google Scholar · View at Scopus
  9. P. Geisser and A. Muller, “Pharmacokinetics of iron salts and ferric hydroxide-carbohydrate complexes,” Drug Research, vol. 37, no. 1 A, pp. 100–104, 1987. View at Google Scholar · View at Scopus
  10. J. E. Toblli and R. Brignoli, “Iron (III)-hydroxide polymaltose complex in iron deficiency anemia: review and meta-analysis,” Drug Research, vol. 57, no. 6 A, pp. 431–438, 2007. View at Google Scholar · View at Scopus
  11. B. J. Schmidt, M. B. Morais, M. Fisberg, A. Martins, and N. L. Machado, “Therapeutic comparison between ferrous sulphate and trivalent iron in the form of a polymaltosed ferric hydroxide complex in organic iron deficiency,” A Folha Médica, vol. 90, pp. 25–29, 1985 (Portuguese). View at Google Scholar
  12. J. Murahovschi, M. L. Stein, R. C. Caraffa et al., “Treatment of iron deficiency and iron deficiency anaemia with an iron hydroxide polymaltose complex given orally in children recovering from respiratory infections. Double blind trial, compared with ferrous sulphate,” Revista Paulista de Pediatria, vol. 5, pp. 97–104, 1987. View at Google Scholar
  13. B. Glader, “Diseases of the blood; section 2—anemias of inadequate protection: iron deficiency anemia,” in Nelson Textbook of Pediatrics, R. M. Kliegman, R. E. Behrman, H. B. Jenson, and B. M. D. Stanton, Eds., pp. 2014–2017, Saunders Elsevier, Philadelphia, Pa, USA, 2007. View at Google Scholar
  14. P. Lanzkowsky, Manual of Pediatric Hematology and Oncology, Elsevier Academic Press, New York, NY, USA, 2005.
  15. D. L. Wong and C. M. Baker, “Pain in children: comparison of assessment scales,” Pediatric Nursing, vol. 14, no. 1, pp. 9–17, 1988. View at Google Scholar · View at Scopus
  16. E. Y. Sözmen, K. Kavakli, B. Çetinkaya, Y. D. Akçay, D. Yilmaz, and Y. Aydinok, “Effects of iron(II) salts and iron(III) complexes on trace element status in children with iron-deficiency anemia,” Biological Trace Element Research, vol. 94, no. 1, pp. 79–85, 2003. View at Publisher · View at Google Scholar
  17. F. A. Haliotis and D. A. Papanastasiou, “Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children,” International Journal of Clinical Pharmacology and Therapeutics, vol. 36, no. 6, pp. 320–325, 1998. View at Google Scholar · View at Scopus
  18. J. V. D. Andrade, P. P. B. Rodrigues, I. B. Fontura, R. D'Agnoluzzo, V. F. Horta, and J. G. B. Alves, “Tratamento da anemia ferropriva com hidroxido de ferro polimatosado,” Arquivos Brasileiros de Medicina, vol. 66, pp. 253–258, 1992. View at Google Scholar
  19. W. Vetter and J. Steurer, “Single-centre, open, randomised, parallel-group study comparing the efficacy and tolerability of oral ferric polymaltose complex in doses of 200 mg, 400 mg and 600 mg per day,” Clinical Report [internal report]. St. Gallen, Switzerland: Vifor (International) Inc. 2000.
  20. R. J. Langstaff, P. Geisser, W. G. Heil, and J. M. Bowdler, “Treatment of iron-deficiency anaemia: a lower incidence of adverse effects with Ferrum Hausmann than ferrous sulphate,” British Journal of Clinical Research, vol. 4, pp. 191–198, 1993. View at Google Scholar · View at Scopus
  21. P. Nielsen, E. E. Gabbe, R. Fischer, and H. C. Heinrich, “Bioavailability of iron from oral ferric polymaltose in humans,” Drug Research, vol. 44, no. 6, pp. 743–748, 1994. View at Google Scholar · View at Scopus
  22. H. C. Heinrich, “Intestinal absorption of 59Fe from neutron-activated commercial oral iron(III)-citrate and iron(III)-hydroxide-polymaltose complexes in man,” Drug Research, vol. 37, no. 1 A, pp. 105–107, 1987. View at Google Scholar · View at Scopus
  23. K. Schümann, H. G. Classen, M. Hages, R. Prinz-Langenohl, K. Pietrzik, and H. K. Biesalski, “Bioavailability of oral vitamins, minerals, and trace elements in perspective,” Drug Research, vol. 47, no. 4, pp. 369–380, 1997. View at Google Scholar · View at Scopus
  24. P. Geisser and S. Burckhardt, “The pharmacokinetics and pharmacodynamics of iron preparations,” Pharmaceutics, vol. 3, no. 1, pp. 12–33, 2011. View at Publisher · View at Google Scholar
  25. P. Jacobs, G. Johnson, and L. Wood, “Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose,” Journal of Medicine, vol. 15, no. 5-6, pp. 367–377, 1984. View at Google Scholar · View at Scopus
  26. C. Brock, H. Curry, and C. Hanna, “Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets,” Clinical Therapeutics, vol. 7, no. 5, pp. 568–573, 1985. View at Google Scholar · View at Scopus
  27. P. Jacobs, L. Wood, and A. R. Bird, “Better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia,” Hematology, vol. 5, no. 1, pp. 77–83, 2000. View at Google Scholar · View at Scopus
  28. T. P. Tuomainen, K. Nyyssönen, E. Porkkala-Sarataho et al., “Oral supplementation with ferrous sulfate but not with nonionic iron polymaltose complex increases the susceptibility of plasma lipoproteins to oxidation,” Nutrition Research, vol. 19, no. 8, pp. 1121–1132, 1999. View at Publisher · View at Google Scholar · View at Scopus
  29. B. Dresow, D. Petersen, R. Fischer, and P. Nielsen, “Non-transferrin-bound iron in plasma following administration of oral iron drugs,” BioMetals, vol. 21, no. 3, pp. 273–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. C. Hutchinson, W. Al-Ashgar, D. Y. Liu, R. C. Hider, J. J. Powell, and C. A. Geissler, “Oral ferrous sulphate leads to a marked increase in pro-oxidant nontransferrin-bound iron,” European Journal of Clinical Investigation, vol. 34, no. 11, pp. 782–784, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Jacobs, L. A. Wormald, and M. C. Gregory, “Absorption of iron polymaltose and ferrous sulphate in rats and humans. A comparative study,” South African Medical Journal, vol. 55, no. 26, pp. 1065–1072, 1979. View at Google Scholar · View at Scopus
  32. L. Jaber, S. Rigler, A. Taya et al., “Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy,” Journal of Pediatric Hematology/Oncology, vol. 32, no. 8, pp. 585–588, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Kavakli, D. Yilmaz, B. Çetinkaya, C. Balkan, E. Y. Sözmen, and F. G. Saǧinz, “Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children,” Pediatric Hematology and Oncology, vol. 21, no. 5, pp. 403–410, 2004. View at Publisher · View at Google Scholar
  34. D. Schellenberg, E. Kahigwa, S. Sanz et al., “A randomized comparison of two anemia treatment regimens in Tanzanian children,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 4, pp. 428–433, 2004. View at Google Scholar · View at Scopus
  35. P. L. Geltman, L. K. Hironaka, S. D. Mehta et al., “Iron supplementation of low-income infants: a randomized clinical trial of adherence with ferrous fumarate sprinkles versus ferrous sulfate drops,” Journal of Pediatrics, vol. 154, no. 5, pp. 738–e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Saha, P. Pandhi, S. Gopalan, S. Malhotra, and P. K. Saha, “Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women,” MedGenMed Medscape General Medicine, vol. 9, no. 1, article 1, 2007. View at Google Scholar · View at Scopus
  37. R. Ortiz, J. E. Toblli, J. D. Romero et al., “Efficacy and safety of oral iron(III) polymaltose complex versus ferrous sulfate in pregnant women with iron-deficiency anemia: a multicenter, randomized, controlled study,” Journal of Maternal-Fetal and Neonatal Medicine, vol. 24, no. 11, pp. 1–6, 2011. View at Google Scholar